High-content cell death imaging using quantum dot-based TIRF microscopy for the determination of anticancer activity against breast cancer stem cell

Journal of Biophotonics
Jieun KiJoon Myong Song

Abstract

We report a two color monitoring of drug-induced cell deaths using total internal reflection fluorescence (TIRF) as a novel method to determine anticancer activity. Instead of cancer cells, breast cancer stem cells (CSCs) were directly tested in the present assay to determine the effective concentration (EC50 ) values of camptothecin and cisplatin. Phosphatidylserine and HMGB1 protein were concurrently detected to observe apoptotic and necrotic cell death induced by anticancer drugs using quantum dot (Qdot)-antibody conjugates. Only 50-to-100 breast CSCs were consumed at each cell chamber due to the high sensitivity of Qdot-based TIRF. The high sensitivity of Qdot-based TIRF, that enables the consumption of a small number of cells, is advantageous for cost-effective large-scale drug screening. In addition, unlike MTT assay, this approach can provide a more uniform range of EC50 values because the average values of single breast CSCs fluorescence intensities are observed to acquire EC50 values as a function of dose. This research successfully demonstrated the possibility that Qdot-based TIRF can be widely used as an improved alternative to MTT assay for the determination of anticancer drug efficacies.

References

Jul 12, 2002·Nature·Paola ScaffidiMarco E Bianchi
Jul 13, 2002·Journal of Pharmaceutical Sciences·David ChauvierMichel Manfait
Jan 11, 2005·The Journal of Pathology·D B Longley, P G Johnston
Apr 2, 2005·Nature Reviews. Cancer·Michael DeanSusan Bates
Jun 16, 2005·The Journal of Investigative Dermatology·Christoph HoellerBurkhard Jansen
Sep 1, 2006·Nature·Roger J P Dawson, Kaspar P Locher
Apr 26, 2008·Phytochemical Analysis : PCA·Ingrid ElisiaDavid D Kitts
Feb 19, 2009·Journal of Mammary Gland Biology and Neoplasia·Michael Dean
Jun 2, 2009·Analytical Chemistry·Christopher B FoxJoel M Harris
Aug 12, 2009·Biosensors & Bioelectronics·Yun-Gon KimUtkan Demirci
May 24, 2011·Biosensors & Bioelectronics·Dong-shan XiangZhi-ke He
Sep 26, 2012·Analytical Chemistry·Yi LongChun-yang Zhang
Oct 20, 2012·Biosensors & Bioelectronics·Francesc A Esteve-Turrillas, Antonio Abad-Fuentes
Feb 19, 2013·Analytical Biochemistry·Jenny LeeBao-Shiang Lee
May 21, 2013·Acta Pharmacologica Sinica·Ke ChenJi-long Chen
Jan 5, 2014·Analytical Chemistry·Yong Yang, Chun-yang Zhang
Apr 22, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chu ChuQingyong Li
Dec 3, 2014·Journal of Ethnopharmacology·P TaylorJ Bajoon
Jan 7, 2015·The Journal of Clinical Investigation·Peter HuebenerRobert F Schwabe
Jun 5, 2015·Methods in Molecular Biology·Oihana IriondoMaría D M Vivanco
Sep 22, 2015·Luminescence : the Journal of Biological and Chemical Luminescence·Hongjing CuiWenying Zhong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis